N
Neuros Biotechnology develops neurogenic therapies focused on treating Alzheimer's disease by addressing neuroplastic deficiency. The company utilizes NB-Px, a human-derived biologic, to rejuvenate neuroplasticity and potentially recover cognition in AD patients. This approach aims to reverse symptoms and prevent further disease progression in individuals with Mild Cognitive Impairment.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Neuros Biotechnology develops neurogenic therapies focused on treating Alzheimer's disease by addressing neuroplastic deficiency. The company utilizes NB-Px, a human-derived biologic, to rejuvenate neuroplasticity and potentially recover cognition in AD patients. This approach aims to reverse symptoms and prevent further disease progression in individuals with Mild Cognitive Impairment.